I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in the field of cardiology from past and present.
All content for 'Why we do What we do in Cardiology' is the property of Bishnu Subedi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in the field of cardiology from past and present.
Lodoco is the first anti-inflammatory approved for reducing cardiovascular events in ASCVD patients.
Bempedoic acid offers an alternative for high-risk patients who can't tolerate statins.
Semaglutide has emerged as a powerful tool for reducing cardiovascular events in overweight or obese patients with pre-existing CVD.
Recaticimab is a long-acting injectable PCSK9 inhibitor requiring less frequent dosing than existing options.
Focus on LDL Cholesterol: New data supports the "power of zero" for coronary artery calcium, prioritizing LDL reduction only in those with established atherosclerosis.
Treat-to-Target vs. High-Intensity Statins: A study (LODESTAR) shows the non-inferiority of the treat-to-target approach, adding to ongoing discussions about cholesterol management strategies.
Overall:
Shift towards prevention: 2023 saw a significant focus on research and interventions aimed at preventing cardiovascular disease rather than solely treating established cases.
Emphasis on early intervention: Studies like POP-HT highlight the importance of monitoring and modifying risk factors in young adulthood.
'Why we do What we do in Cardiology'
I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in the field of cardiology from past and present.
